Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
DSM - Inkoop eigen aandelen (6 - 12 oktober 2011) Heerlen, NL, 13 oktober 2011 09:15 CET Koninklijke DSM, de wereldwijde Life Sciences en Materials Sciences-onderneming, heeft ingekocht 391.817 eigen aandelen in de periode van 6 oktober 2011 tot en met 12 oktober 2011 tegen een gemiddelde prijs van € 35,51. Dit is in overeenstemming met de inkoop, waarbij de bestaande aandelenoptieplannen, kondigde op 7 september 2011. De overweging van deze inkoop was € 13,9 miljoen. Het totaal aantal ingekochte aandelen onder dit programma is tot dusver 2.479.662 aandelen voor een totaal bedrag van € 80,8 millio
RBS' Flop 11 19 oktober 2011 - 15:54u RBS verwacht Europese recessie en 25% winstdaling en zet daarom mes in adviezen en koersdoelen elf Nederlandse aandelen. Wie? Niet tien, niet twaalf, nee maar liefst zeventien Nederlandse fondsen neemt RBS vandaag in een speciaal Benelux Equities rapport onder de loep. De Britten schuwen daarbij niet advieswijzingen en vooral – koersdoelverlagingen van vele tientallen procenten. Verlagingen, want er zit geen enkele verhoging bij. Wat maakt RBS zo bearish? De bank valt met de deur in huis: “Onze economen voorspellen dat Europa nog voor het einde van het jaar een recessie tegemoet gaat, die wij in de schattingen meenemen. Daarom verlagen wij onze winst per aandeelschattingen met gemiddeld 25%.In deze fase van de economische cyclus moeten beleggers een uitgebalanceerde portfolio hebben van cyclische en defensieve aandelen.” Favorietenlijst Gefilterd voor Belgische aandelen ziet et favorietenlijstje van RBS ziet er als volgt uit, met soms de moeilijk of niet te vertalen omschrijvingen in het Engels: Long CSM: bombed-out defensive DSM en Boskalis Westminster: quaility high bèta Imtech: secular growth Short Air France-KLM: cyclisch Heineken: defensief Toppers CSM: buy – 14 euro CSM is our contrarian valuation call. It’s unloved and bombed out, but darn cheap. With so many negatives out in the open, we believe it would difficult for CSM to disappoint again. Following two profit warnings, CSM is one of the worst performers in the Benelux in 2011. DSM: buy – 54 euro We like DSM for its exposure to Nutrition (roughly 60% of EBIT) business. Furthermore, we believe the company’s war chest of close to €2.0bn should provide a positive trigger in this buyer’s market. Boskalis-Westminster: buy – 29 euro Boskalis continues to believe that some €50bn worth of dredging orders will come to the market through 2015. Tender activity remains high. We expect earnings recovery in 2013. The shares look cheap at an 18-39% discount to historical valuation metrics. Imtech: buy – 26 euro The current orderbook of €5.7bn exceeds one year of sales and the long-term drivers remain intact. We include recent acquisitions in our forecasts, but lower our organic growth forecasts. Floppers Air France-KLM: sell – 4,75 euro Recent commentary from airlines has identified weakening cargo and long-haul economy class demand, but we have yet to see a softening in long-haul premium travel demand. We strongly expect that long-haul premium demand will weaken this winter. Heineken: hold – 34 euro “We have a more cautious view on consumer spending, especially in the developed world. Consumer Staples numbers will hold up better than those of most other sectors, but if 2009 is a guide, the sector is not immune and we can expect downgrades of about 15% Flop 10 Dan nu die tien aandelen waar RBS het mes in zet, met de belangrijkste beweegredenen daarvoor: Aegon: hold – 3,80 euro (was 5,70 euro) We believe Aegon is in a better position in this downturn than the previous one, because of de-risking and a stronger capital position. As such, we expect AEGON will be able to continue its dividend payments. We keep our Hold rating as we prefer ING. AkzoNobel: hold (was buy) – 36 euro (was 54 euro) Momentum is clearly negative for AkzoNobel, although most of this should be priced in. Raw material deflation and cost savings in 2012 could help, but will be partly offset by down-trading. We see therefore no significant upside from these levels. Beter Bed: hold – 16 euro (was 19 euro) We like Beter Bed's business model, but we choose to remain cautious. We lower our FY12/13F estimates by 8% on average to reflect our cautious stance on lfl growth and new store openings. Fugro: buy – 50 euro (was 65 euro) Organic growth should level off quickly in 2H11. We lower our 2012 margin forecasts by 24%, as we take out all organic growth and margin expansion from our model for the foreseeable future. ING: buy – 8 euro (was 10 euro) Though the divestment of ING Insurance might be delayed, we expect ING Bank's relatively strong capital position will enable it to repay the government capital. We believe the valuation remains attractive at 0.6x 2011F TCE and 6x 2012F EPS. MacIntosh: hold: 13 euro (was 17 euro) We include a mild recession in our model and lower our organic growth forecast from flat to -2% for 2012. Given the leverage in the P&L, this drop reduces our 2012F EBIT by 17%. Randstad: buy – 40 euro (was 53 euro) Our model is based on a macro-environment similar to 2002-03. In this scenario, revenues would fall 3% organically in FY12, while margins would fall 20bp. Our new €40 TP is based on a mid-cycle EV/net-fee multiple of 2.5x. TKH Group: buy- 18 euro 9was 20 euro) We include a mild recession in our model and lower our organic growth forecast from flat to -2% for 2012. Given the leverage in the P&L, this drop reduces our 2012F EBIT by 17%. TomTom: buy - 7 euro (was 8 euro) We believe the recent client wins in the automotive division and significant cost savings in FY12 will compensate for the lower PND revenues, hence EPS will be flat in FY12 yoy. USG People: 12 euro (was 18 euro) In our model, we effectively replicate market developments seen in 2002/03. In this scenario, revenues would drop 3% organically in 2012, while margins would drop 30bp. Our new TP of €12 is driven by a mid-cycle EV/net fee multiple of 2.0x. Van Lanschot: sell – 22 euro (was 28 euro) While Van Lanschot is improving its business mix, the weak economic and market outlook imply that normalised earnings cannot be reached before 2015. At 0.8x 2011F TCE and 15.6x 2012F EPS, it is trading at a hefty premium to its Benelux peers.
DSM verwacht sterke toename biobrandstof 19 oktober 2011 17:52 AMSTERDAM - Het Nederlandse chemieconcern DSM verwacht de komende jaren een explosieve toename van het gebruik van biobrandstof uit afval in plaats van gewassen. Dat zei bestuurslid Stephan Tanda van het bedrijf woensdag tijdens een tweedaags congres over biotechnologie in Amsterdam. Volgens DSM zal de markt voor brandstoffen die geproduceerd worden uit organisch afval en gewassen over een paar jaar een markt kennen waar jaarlijks tussen de 3 en 4 miljard euro in omgaat. DSM produceert enzymen die de verbranding van groene afvalstoffen voor de productie van energie mogelijk maken. ANP
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)